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Introduction
Ischemic stroke during or after cardiac catheterization/
percutaneous cardiac intervention (PCI) is a rare but
catastrophic complication. Risk factors include diabetes
mellitus, hypertension, increased age, prior stroke, and
renal insufficiency. Moreover, the technique of catheter
manipulation, emergent cardiac procedures, interven-
tions for vein grafts, and unplanned insertion of an
intra-aortic balloon pump are predictors of this com-
plication. Management of such events is challenging
to all interventional cardiologists, because there is no
standard treatment for this complication. Immediate
cranial computed tomography or magnetic resonance
image (MRI) with magnetic resonance angiography
(MRA) is essential to evaluate new neurologic deficits
noted after PCI. Prompt cerebral angiography can be
considered in selective situations for diagnosis and
treatment. We present an elderly person who had suf-
fered from sudden neurologic deficits on-table after PCI
in our catheterization laboratory. Ischemic stroke was
proven by emergent cranial MRI with MRA. In our report,
we discuss the characteristics of acute ischemic stroke
after PCI and how to manage this serious complication
in clinical practice.
Case Report
An 83-year-old man with a medical history of hyper-
tension and renal insufficiency was admitted to our
hospital because of angina pectoris. He could not ac-
complish the treadmill exercise test because of osteo-
arthritis of bilateral knee joints. Besides, he refused a
myocardial perfusion image study. Echocardiogram re-
vealed a significant hypokinesis of the inferior wall of
the left ventricle. Cardiac catheterization was suggested
by the interventional cardiologist and was performed
the day after admission. Before the cardiac procedure
went ahead, the patient’s chest X-ray revealed a tortu-
ous aorta, and the electrocardiogram showed a regular
sinus rhythm with ST depression in leads II, III and aVF.
In the catheterization laboratory, coronary angiography
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showed significant stenosis (> 80%) of the proximal to
the middle segment of the right coronary artery. One
bare-metal stent was deployed on the diseased segment
of right coronary artery without hemodynamic insta-
bility or uncomfortable symptoms. Diagnostic and guid-
ing catheters were advanced through the transradial
sheath. In spite of widening and tortuosity of the aor-
tic root, ostia of coronary arteries were engaged by
catheters without much manipulation. All procedures
were performed following standard practice with care-
fully checking back-bleeding whenever catheters were
advanced. An air bubble was also expelled by meticu-
lous flushing with heparinized saline. Unfractionated
heparin was used at a total amount of 7,000 U. The
fluoroscopic time during our procedure was within 
30 minutes. The total amount of contrast used for
diagnostic angiography and PCI was less than 100 mL.
After PCI, we noticed that the patient presented with a
lethargic appearance with sudden right limb weakness
in our catheterization laboratory. Cranial MRI with
MRA was performed emergently within 30 minutes.
Cranial MRI showed a high signal intensity at the left
upper temporal cortex and posterior frontal lobe in
diffusion-weighted imaging (Figure 1). MRA revealed
severe stenosis of the left vertebral artery and branches
of left middle cerebral artery (Figure 2). All images were
reviewed by an experienced radiologist and neurolo-
gist immediately, and the diagnosis of acute ischemic
stroke was confirmed. We explained this situation to
the family. They refused thrombolytic therapy and cere-
bral angiography. Adequate rehabilitation was planned
and performed during hospitalization. This patient was
discharged from our hospital after 14 days with partial
recovery of motor and speech function.
Discussion
Although the overall rate of ischemic strokes during or
after cardiac catheterization/PCI is low, ranging from
0.18% to 0.40%1–3, it is the most debilitating compli-
cation associated with a high rate of morbidity and
mortality. However, low incidence and inexperience
with this complication in a catheterization laboratory
preclude operators from choosing an immediate and
adequate management. The incidence of this compli-
cation is perhaps underestimated because of the
increasingly high volume of cardiac procedures in the
current era. The occurrence of mild transient ischemic
attacks is another possible reason for the underesti-
mation, because transient and mild symptoms or signs
can be easily ignored by clinicians.
Ischemic strokes are usually embolic and could
have many origins. For the purpose of left ventriculog-
raphy, dislodged calcified particles from a stenotic aor-
tic valve by retrograde catheterization would cause
embolization to the brain4. Catheter tips traversing the
aortic arch could dislodge atheromatous plaques, which
embolize cerebral circulation. Keeley and Grines5 ob-
served plaque dislodgment off the aortic arch with
catheter advancement in more than 50% of 1,000 PCI
procedures studied. Thus, inadequate and frequent
catheter manipulation during cardiac procedures would
increase risks of cerebral embolization. During urgent
procedures, unplanned insertion of an intra-aortic
balloon pump and less meticulous care in advancing
the catheter through the aorta increase the chance of
scraping aortic plaques with subsequent embolization.
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Figure 1. Immediate cranial magnetic resonance imaging
showing high signal intensity at the left upper temporal cortex
and posterior frontal lobe in diffusion-weighted imaging.
Figure 2. Magnetic resonance angiography revealing severe
stenosis of the left vertebral artery and branches of left mid-
dle cerebral artery.
Besides, hemodynamic instability in emergent situa-
tions and low cardiac output would further compro-
mise cerebral perfusion and worsen ischemic events.
Thrombus formation in situ on catheter tips is another
possible source of embolism6. Other embolic origins in-
clude air emboli and fragmented interventional devices.
In 20,679 consecutive patients who underwent PCI
in a large-volume center reported by Dukkipati et al.2,
cerebral infarction after angioplasty could be attributed
to the following artery distributions: middle cerebral in
56%, anterior cerebral in 2%, posterior cerebral in 37%,
superior cerebellar in 5%, posterior inferior cerebellar
in 5%, and basilar in 7%. In the report by Dukkipati et al.,
infarcts to the anterior circulation represented 58%,
and those to the posterior circulation represented
54%. This finding is of interest, because only about
20% of blood flow to the brain traverses the posterior
circulation. One possible explanation is that the an-
atomy of the branches from the aortic arch probably
favors small emboli entering the vertebral arteries7.
Ischemic strokes after angioplasty mostly presented with
motor and speech deficits2. The interventional cardio-
logists should become aware of this point and observe
their patients closely after procedures.
Risk factors of periprocedural ischemic stroke in-
clude diabetes mellitus, hypertension, increased age,
prior stroke, and renal insufficiency2,3. Patients with
chronic renal insufficiency often have concomitant car-
diovascular and cerebrovascular risk factors, such as
diabetes mellitus and hypertension. Diabetes and hyper-
tension predispose to occlusive disease of intracranial
and extracranial arteries. The preexisting neurovascu-
lar and systemic vascular compromise greatly reduces
cerebrovascular reserve and hampers the ability of the
brain to tolerate embolization. The immediate and
longer-term consequences of this complication are
devastating in terms of both morbidity and mortality,
with a risk of in-hospital death of greater than 35%
and a tenfold increase in 1-year mortality8.
The first aim of those sudden neurologic deficits in
the catheterization laboratory is to confirm that the
acute event is due to a stroke or other diseases (e.g.,
seizure, migraine, encephalopathy, and hypoglycemia).
Currently, no standard treatment for periprocedural
ischemic stroke exists. Intravenous thrombolytic therapy
with recombinant tissue plasminogen activator within
3 hours of ischemic stroke symptom onset has been
shown to be efficacious in the general stroke popula-
tion9. However, the benefits and risks of this therapy
for periprocedural ischemic strokes are unclear. Hem-
orrhagic risk is the most critical concern if there is 
concomitant administration of heparin or glycoprotein
IIb/IIIa inhibitor, which are usually used in PCI. The use
of intra-arterial thrombolysis in heparinized patients
is not recommended10, and the PROACT-I trial11 showed
significantly higher rates of hemorrhagic transformation
in intra-arterial thrombolytic-treated patients given high-
dose heparin (approximately 10,000 U) compared with
the lower doses (approximately 3,000 U). The risks of
recombinant tissue plasminogen activator for stroke
in the presence of glycoprotein IIb/IIIa inhibitors is not
known, although preliminary data based on some small
series of patients with stroke treated with the combina-
tion of these agents suggest potential safety6,12. De Marco
et al.13 reported six cases of periprocedural ischemic
stroke complicating cardiac catheterizations in which
immediate cerebral angiography was the key factor in
their successful management. Cerebral angiography
allows identification of the occluded vessels and offers
reperfusion by mechanical means (e.g., thrombus aspi-
ration, retrieval of a fractured device) or selective throm-
bolysis with a greater chance of recanalization than
with intravenous thrombolysis14,15. Although thrombo-
lytic therapy is deemed to be safe and efficacious in
some small studies6,13–15, its utility remains to be de-
termined for various origins of embolization. For exam-
ple, if dislodged aortic arch plaque is the predominant
origin, this calcified clot may not be amenable to lytic
therapy. Conversely, a fresh thrombus on the tip of
catheters or guidewire may be easier to destabilize6,14.
In our report, an 83-year-old male suffered from acute
ischemic stroke attributed to left middle cerebral artery
territories after PCI. Although this elective procedure
was accomplished following the standard process by
an experienced operator and team, acute ischemic
stroke was still the unfortunate occurrence. An embolic
origin may be produced from multiple atheromatous
plaques scraped by catheter tips or from tiny throm-
bus formation on catheters, which cannot be easily
seen during procedures. A moderate amount of heparin
used in PCI precluded the family’s and clinician’s deci-
sion for thrombolytic therapy. This unexpected event
taught us that every procedure should be performed
carefully.
In conclusion, acute ischemic stroke is one of the
most catastrophic complications of PCI. Coronary inter-
ventional procedures must be performed with meticu-
lous attention to technical detail. Immediate cranial
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MRI with MRA or computed tomography is critical to
assess any neurologic deficits of patients during or after
procedures. Cerebral angiography can be considered for
selective thrombolysis or endovascular interventions
such as thrombus aspiration and retrieval of fractured
devices. Whether thrombolysis is safe and efficacious
remains to be determined, but the existing evidence
from some small studies seems favorable. Thrombo-
lytic therapy should be used under prompt evaluation
for bleeding risks. Expeditious management including
a multidisciplinary response team, including an in-
terventional cardiologist, neurologist, radiologist and,
potentially, a neurointerventionalist, is required to
facilitate immediate imaging and treatment16,17.
References
1. Wong SC, Minutello R, Hong MK. Neurological compli-
cations following percutaneous coronary interventions
(a report from the 2000–2001 New York State Angioplasty
Registry). Am J Cardiol 2005; 96: 1248–50.
2. Dukkipati S, O’Neill WW, Harjai KJ, et al. Characteristics
of cerebrovascular accidents after percutaneous coro-
nary interventions. J Am Coll Cardiol 2004; 43: 1161–7.
3. Hamon M, Baron JC, Viader F, et al. Periprocedural
stroke and cardiac catheterization. Circulation 2008;
118: 678–83.
4. Omran H, Schmidt H, Hackenbroch M, et al. Silent and
apparent cerebral embolism after retrograde catheteri-
sation of the aortic valve in valvular stenosis: a prospec-
tive, randomised study. Lancet 2003; 361: 1241–6.
5. Keeley EC, Grines CL. Scraping of aortic debris by coronary
guiding catheters: a prospective evaluation of 1,000
cases. J Am Coll Cardiol 1998; 32: 1861–5.
6. Khatri P, Kasner SE. Ischemic strokes after cardiac
catheterization: opportune thrombolysis candidates?
Arch Neurol 2006; 63: 817–21.
7. Bittl JA, Caplan LR. Stroke after percutaneous coronary
interventions. J Am Coll Cardiol 2004; 43: 1168–9.
8. Fuchs S, Stabile E, Kinnaird TD, et al. Stroke complicating
percutaneous coronary intervention: incidence, predic-
tors, and prognostic implications. Circulation 2002; 106:
86–91.
9. Demaerschalk BM, Yip TR. Economic benefit of increas-
ing utilization of intravenous tissue plasminogen activa-
tor for acute ischemic stroke in the United States. Stroke
2005; 36: 2500–3.
10. Adams H, Adams R, Del Zoppo G, et al. Guidelines for
the early management of patients with ischemic stroke:
2005 guidelines update a scientific statement from the
Stroke Council of the American Heart Association/
American Stroke Association. Stroke 2005; 36: 916–23.
11. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a
phase II randomized trial of recombinant pro-urokinase
by direct arterial delivery in acute middle cerebral artery
stroke. Stroke 1998; 29: 4–11.
12. Deshmukh VR, Fiorella DJ, Albuquerque FC, et al. Intra-
arterial thrombolysis for acute ischemic stroke: prelimi-
nary experience with platelet glycoprotein IIb/IIIa
inhibitors as adjunctive therapy. Neurosurgery 2005;
56: 46–55.
13. De Marco F, Antonio Fernandez-Diaz J, Lefèvre T, et al.
Management of cerebrovascular accidents during car-
diac catheterization: immediate cerebral angiography
versus early neuroimaging strategy. Catheter Cardiovasc
Interv 2007; 70: 560–8.
14. Khatri P, Taylor RA, Palumbo V, et al. The safety and effi-
cacy of thrombolysis for strokes after cardiac catheteri-
zation. J Am Coll Cardiol 2008; 51: 906–11.
15. Arnold M, Fischer U, Schroth G, et al. Intra-arterial throm-
bolysis of acute iatrogenic intracranial arterial occlu-
sion attributable to neuroendovascular procedures or
coronary angiography. Stroke 2008; 39: 1491–5.
16. Lyden PD. Code stroke in the cath lab. J Am Coll Cardiol
2008; 51: 912.
17. Janjua N, Brisman JL. Endovascular treatment of acute
ischaemic stroke. Lancet Neurol 2007; 6: 1086–93.
International Journal of Gerontology | March 2010 | Vol 4 | No 146
■ ■C.F. Lin et al
